Best Immunotherapy doctors in Ramat Gan: TOP 8 doctors

Prof. Amit Tirosh leads the Neuroendocrine Tumors Service at Sheba Medical Center, specializing in complex hereditary syndromes.

• Expert in Peptide Receptor Radionuclide Therapy (PRRT)
• Head of the Endocrine Oncology Bioinformatics Laboratory
• Affiliated with NIH for MEN1 syndrome research
• Author of 40+ publications on neuroendocrine tumors
• Part of international expert panels on VHL disease

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Dr. Hana Golan

MD | Pediatric Hematology-Oncology & Bone Marrow Transplant Specialist

Department:

Pediatric Hemato-Oncology & BMT Division, Sheba Medical Center

Languages:

Hebrew, English

Professional Summary

Dr. Hana Golan is a leading pediatric hemato-oncologist and Director of the Pediatric Hemato-Oncology and Bone Marrow Transplant (BMT) Division at Sheba Medical Center. She specializes in the treatment of childhood cancers and complex hematological disorders, with a particular focus on neuroblastoma and high-risk solid tumors.

With decades of clinical and research experience, Dr. Golan combines advanced oncology protocols with personalized treatment strategies aimed at improving outcomes in challenging pediatric cases.

Areas of Expertise

Pediatric oncology (solid tumors and hematologic malignancies)

Neuroblastoma (including high-risk cases)

Bone marrow and stem cell transplantation

Leukemia and lymphoma in children

Chronic and inherited blood disorders

Immune deficiencies and metabolic disorders

Personalized chemotherapy and targeted therapy protocols

Education & Training

MD, Rappaport Faculty of Medicine, Technion – Israel Institute of Technology

Residency in Pediatrics, Sheba Medical Center

Residency in Pediatric Hematology-Oncology, Sheba Medical Center

Advanced research training in transplantation immunology, Weizmann Institute of Science

Additional training in clinical research, biomedical informatics, and healthcare management

Clinical & Research Experience

Dr. Golan leads one of the most advanced pediatric oncology programs in the region, managing complex and high-risk cases. She is actively involved in the development and implementation of international treatment protocols, particularly in neuroblastoma.

Her research focuses on:

cancer stem cells in pediatric tumors

development of targeted therapies

novel approaches to treatment-resistant malignancies

emerging therapeutic strategies, including cannabinoid-related research in oncology

Clinical Trials & International Collaboration

Principal Investigator of the High-Risk Neuroblastoma ESIOP protocol

Investigator in international Phase I/II clinical trials targeting advanced pediatric cancers

National coordinator of multicenter oncology protocols

Academic & Teaching Roles

Senior Lecturer, Sackler Faculty of Medicine, Tel Aviv University

Lecturer in pediatric hematology-oncology for physicians and nurses

Coordinator of hematology training programs for medical students

Leadership & Innovation

Director, Pediatric Hemato-Oncology and BMT Division

Led implementation of computerized chemotherapy protocols and patient databases

Developed systems to improve clinical workflow and patient safety

Board Certifications

Pediatrics

Pediatric Hematology-Oncology

Selected Publications

Primary immunodeficiency syndromes in Israel

Integration of palliative care in pediatric oncology

Additional peer-reviewed publications in pediatric cancer treatment

Why Patients Choose Dr. Golan

Extensive experience in complex pediatric oncology cases

Leadership in international clinical trials and treatment protocols

Expertise in neuroblastoma and high-risk pediatric tumors

Multidisciplinary approach combining treatment, research, and supportive care

Practice within a Top-10 globally ranked hospital

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Prof. Ben Boursi leads groundbreaking research on microbiome's role in cancer therapy – his work is published in Science and featured at ASCO.

• Specializes in gastrointestinal oncology at Sheba Medical Center
• Trained at University of Pennsylvania and top US cancer centers
• Founder of ECOG-ACRIN Microbiome Working Group
• Develops predictive models for early cancer detection
• Board-certified in both Internal Medicine and Medical Oncology

Dr. Eytan Aharon Ben-Ami, MD

Senior Physician, Sarcoma & Bone Oncology Service – Sheba Medical Center

Leading Expert in Sarcoma, Bone Tumors & Innovative Cancer Therapies

Dr. Eytan Ben-Ami is a highly specialized medical oncologist with extensive experience in the treatment of sarcomas and complex bone tumors, including rare and aggressive cancers.

As a senior physician at Sheba Medical Center, he plays a key role in delivering multidisciplinary, highly personalized care, often collaborating with pediatric and adult oncology teams to manage challenging soft tissue and bone malignancies.

Areas of Expertise

• Sarcoma (Core Expertise)
  Soft tissue sarcomas, liposarcoma, leiomyosarcoma, and rare tumor subtypes
•  
• Bone Oncology
  Osteosarcoma and other primary bone tumors
•  
• Advanced Medical Oncology
  • Targeted therapies and immunotherapy
  •  
  • Personalized treatment protocols for rare cancers
  •  
• Early-Phase Clinical Trials (Phase I)
  Access to innovative and next-generation cancer treatments

Clinical Leadership & Innovation

Dr. Ben-Ami is at the forefront of oncology innovation at Sheba, contributing to:

• Leadership in early-phase (Phase I) clinical trials, offering patients access to cutting-edge therapies
• Development of new treatment approaches for rare cancers
• Implementation of patient-centered innovations, including novel care delivery models

He also founded Sheba’s Clinical Research Organization (CRO), a pioneering initiative supporting advanced clinical research across multiple disciplines.

International Training & Expertise

Dr. Ben-Ami completed a prestigious fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute / Harvard Cancer Center, one of the world’s leading cancer research institutions.

His approach combines:

• Global expertise in rare tumor management
• Advanced diagnostics and precision oncology
• Access to innovative therapies not widely available

Leadership & Academic Roles

• Senior Physician, Sarcoma & Bone Oncology Service, Sheba Medical Center
• Head of Oncology Division & Early-Phase Clinical Trials Unit
• Founder, Sheba Clinical Research Organization (CRO)
• Academic affiliation with Tel Aviv University

Research & Scientific Contribution

Dr. Ben-Ami is an active researcher with 40+ scientific publications, focusing on:

• Early detection and monitoring of sarcomas
• Molecular and viral mechanisms in rare tumors
• Development of innovative oncology treatments

He is also leading pilot programs in advanced immunotherapy delivery, improving accessibility and patient experience.

Clinical Approach

Dr. Ben-Ami is known for managing complex and rare cancer cases, offering:

• Highly individualized treatment strategies
• Multidisciplinary collaboration across oncology, surgery, and pediatrics
• Access to breakthrough therapies through clinical trials

Patient-Centered Care

Dr. Ben-Ami provides advanced, compassionate oncology care, combining cutting-edge science with a personalized approach, ensuring patients receive the most effective and innovative treatment options available.

A Leader in Rare Cancer Treatment

Through his expertise in sarcoma, bone oncology, and early-phase clinical research, Dr. Ben-Ami offers patients access to one of the most advanced programs globally for rare and complex cancers.